Literature DB >> 4745868

Brief communication: Cure of murine leukemia with drug and interferon treatment.

M A Chirigos, J W Pearson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4745868     DOI: 10.1093/jnci/51.4.1367

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

Review 1.  Interferon in 1987: the half full glass.

Authors:  S E Krown
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 2.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

3.  The role of alpha interferon in the biomodulation of disease: preface.

Authors:  S Wadler
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

4.  Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential.

Authors:  M A Chirigos; J E Talmadge
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Combining interferon with cytotoxic chemotherapy in patients with advanced breast cancer.

Authors:  R Ashford; T Priestman; T Mott; J M Bottomley
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment.

Authors:  M J Yagi; N W King; J G Bekesi
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

7.  Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay.

Authors:  M S Aapro; D S Alberts; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

8.  A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma.

Authors:  J Wagstaff; P Loynds; D Crowther
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.

Authors:  N Hirabayashi; K Yoshinaka; Y Nosoh; T Toge; M Niimoto; T Hattori; T Ohkita
Journal:  Jpn J Surg       Date:  1985-07

10.  Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.

Authors:  M Ono; N Tanaka; K Orita
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.